Related Experiment Video
Updated: May 25, 2026
07:10
High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies
Published on: September 29, 2023
Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy
Tristan M Sissung1, Sarah M Troutman, Tessa J Campbell
1Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Discovery Medicine
|January 31, 2012
Summary
Genetic variants in drug transporters significantly impact how individuals respond to medications and their susceptibility to diseases. Understanding these genetic differences is crucial for personalized medicine and effective pharmacotherapy.
Area of Science:
- Pharmacogenomics
- Molecular Biology
- Clinical Pharmacology
Background:
- Drug transporters are critical for moving substances across cell membranes.
- They influence physiological processes, disease development, and drug effectiveness.
- Genetic variations in transporters lead to significant inter-individual differences in drug response.
Purpose of the Study:
- To review the association between inherited genetic variants in drug transporters and disease.
- To explore the impact of these variants on disease etiology, state, and treatment.
- To provide examples illustrating the broad scope of research in transporter genetics and medicine.
Main Methods:
- Literature review of published studies on transporter genetics and medicine.
- Synthesis of findings linking genetic variants to disease and pharmacotherapy.
- Exemplification of key research areas and their clinical implications.
Main Results:
- Inherited genetic variants in drug transporters are demonstrably linked to disease development and progression.
- These genetic variations significantly alter drug pharmacokinetics and pharmacodynamics, affecting treatment outcomes.
- Population-specific differences in transporter genetics contribute to variable responses to medications.
Conclusions:
- Genetic variations in drug transporters play a pivotal role in human health and disease.
- Understanding transporter genetics is essential for advancing personalized medicine and optimizing pharmacotherapy.
- Further research is warranted to fully elucidate the clinical impact of transporter genetic diversity.
Related Concept Videos
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Nonlinear Pharmacokinetics: Role of Transporters
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...